West Pharmaceutical Services | WST - Operating Profit


West Pharmaceutical Services reported $177.1M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Align Technology USD 178.05M 46.66M Mar/2026
Avanos Medical USD 8.9M 15.87M Mar/2026
Baxter International USD 66M 280.2M Mar/2026
Becton, Dickinson and Co. USD 627M 36M Mar/2026
Cerus USD -1.45M 488K Dec/2024
Charles River Laboratories USD 119.9M 44.08M Mar/2026
Cooper Companies USD -31M 243.8M Mar/2026
Dentsply International USD 32M 506M Mar/2026
Haemonetics USD 67.4M 8.9M Dec/2025
ICU Medical USD 26.09M 770K Dec/2025
Insulet USD 122M 24.3M Mar/2026
Integra LifeSciences USD 11.47M 54.54M Mar/2026
IQVIA Holdings USD 565M 2.11B Mar/2026
J&J USD 7.48B 860M Jun/2026
Medtronic USD 2.09B 354M Mar/2026
Merit Medical Systems USD 44.16M 10.04M Mar/2026
Neogen USD -3.3M 2.08M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Quidel USD -31.8M 5.5M Mar/2026
Repligen USD 19.98M 13K Mar/2026
Rockwell Medical USD 515K 1.84M Jun/2024
Solventum Corp USD 85M 20M Mar/2026
STAAR Surgical USD 17.4M 28.34M Mar/2026
Terumo JPY 31.45B 12.43B Mar/2026
Utah Medical Products USD 2.44M 1.32M Dec/2025
West Pharmaceutical Services USD 177.1M 14.6M Mar/2026